{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:14:24Z","timestamp":1790727264358,"version":"4.1.0"},"reference-count":28,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"King Hussein Cancer Center (Amman, Jordan)","award":["25KHCC222"],"award-info":[{"award-number":["25KHCC222"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Choroidal hemangioma, a rare benign vascular tumor, can cause visual loss due to subretinal fluid. Photodynamic therapy (PDT) with verteporfin has been the standard treatment, with plaque brachytherapy reserved for PDT failure. Verteporfin is unavailable in many regions in the Middle East, including Jordan, leaving plaque as the main alternative; however, plaque often leads to poor visual outcomes despite tumor control. To improve visual outcomes, we introduced transpupillary thermotherapy (TTT) via laser indirect ophthalmoscopy (LIO) as a practical, widely available, vision-preserving treatment. Methods: We retrospectively reviewed 13 patients with choroidal hemangioma treated at King Hussein Cancer Center. Patients received either plaque brachytherapy or LIO-guided TTT. Clinical data included visual acuity at baseline, tumor thickness reduction, subretinal fluid status, and visual outcome. Results: All patients had unilateral circumscribed choroidal hemangioma, and 10 (77%) were males. At diagnosis, the visual acuity was \u22640.5 in all patients (100%) and &lt;0.1 in six (46%) patients. Seven patients (54%) received LIO-guided TTT and six (46%) underwent I-125 plaque brachytherapy. Tumor thickness was 3.0\u20135.0 mm in 12 (92%) cases; the median thickness in the I-125 plaque brachytherapy group was 4.5 mm (range, 4.5\u20135.0 mm), whereas in the LIO-guided TTT group it was 3.8 mm (range, 2.9\u20135.0 mm). At a median follow-up of 20 months (mean 24, range 12\u201348 months), five out of seven patients (71%) treated with TTT showed significant visual improvement, while the remaining two (29%) had stable vision; none experienced deterioration. In contrast, none of the six plaque-treated patients (0%) demonstrated any improvement in visual acuity; four remained stable and two worsened. This difference was statistically significant (p = 0.021). Tumor thickness was reduced in both groups, with a median reduction of \u221256% in the plaque group and \u221236% in the TTT group. All patients achieved complete resolution of subretinal fluid. Conclusions: LIO-guided TTT is an effective vision-preserving treatment for choroidal hemangioma. While both modalities-controlled tumor growth, only TTT resulted in significant visual improvement. This study demonstrates that LIO-guided TTT can replace plaque brachytherapy in regions where verteporfin (PDT) is unavailable, offering an accessible, practical, and superior alternative for preserving vision in patients with choroidal hemangioma.<\/jats:p>","DOI":"10.3390\/cancers17183087","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:05:17Z","timestamp":1758535517000},"page":"3087","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Laser Indirect Ophthalmoscopy-Guided Transpupillary Thermotherapy Versus I-125 Plaque Brachytherapy for Choroidal Hemangioma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1220-2885","authenticated-orcid":false,"given":"Rima","family":"Torosyan","sequence":"first","affiliation":[{"name":"Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Jaradat","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"AlJabari","sequence":"additional","affiliation":[{"name":"Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"AlNawaiseh","sequence":"additional","affiliation":[{"name":"Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7750-6454","authenticated-orcid":false,"given":"Yacoub A.","family":"Yousef","sequence":"additional","affiliation":[{"name":"Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman 11941, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.sjopt.2019.07.002","article-title":"Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases","volume":"33","author":"Dalvin","year":"2019","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13816810.2022.2090008","article-title":"Retinoblastoma and uveal melanoma in Jordan: Incidence, demographics, and survival (2011\u20132020)","volume":"44","author":"Yousef","year":"2023","journal-title":"Ophthalmic Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.4103\/ijo.IJO_2036_19","article-title":"Circumscribed choroidal hemangioma: An overview of clinical manifestation, diagnosis and management","volume":"67","author":"Sen","year":"2019","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/13816810.2021.1910963","article-title":"Current concepts on diffuse choroidal hemangioma in Sturge-Weber syndrome","volume":"42","author":"Formisano","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12519-024-00809-y","article-title":"Sturge-Weber syndrome: An update for the pediatrician","volume":"20","author":"Dingenen","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103000","DOI":"10.1016\/j.pdpdt.2022.103000","article-title":"Photodynamic therapy in the treatment of circumscribed choroidal hemangioma: Current perspectives","volume":"39","author":"Kumar","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.survophthal.2025.01.001","article-title":"Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma","volume":"70","author":"Yang","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kreminger, J.E., Told, R., Rokitansky, S., Reumueller, A., Dunavoelgyi, R., and Sacu, S. (Can. J. Ophthalmol., 2025). Choroidal features on widefield optical coherence tomography angiography in eyes with circumscribed choroidal hemangioma, Can. J. Ophthalmol., in press.","DOI":"10.1016\/j.jcjo.2025.07.002"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/IAE.0000000000004323","article-title":"Intravitreal Bevacizumab for the Treatment of Choroidal Hemangiomas","volume":"45","author":"Elkayal","year":"2025","journal-title":"Retina"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.oret.2017.12.002","article-title":"Analysis of Long-term Outcomes of Radiotherapy and Verteporfin Photodynamic Therapy for Circumscribed Choroidal Hemangioma","volume":"2","author":"Papastefanou","year":"2018","journal-title":"Ophthalmol. Retin."},{"key":"ref_11","first-page":"e50461","article-title":"Safety and Efficacy of Photodynamic Therapy in the Treatment of Circumscribed Choroidal Hemangioma: A Systematic Review","volume":"15","author":"Alshehri","year":"2023","journal-title":"Cureus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.sjopt.2017.12.002","article-title":"Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan","volume":"32","author":"Jaradat","year":"2018","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jeon, J., Byeon, H.J., Byeon, S.H., Kim, S.S., and Lee, C.S. (Br. J. Ophthalmol., 2025). Predicting the therapeutic effect of photodynamic therapy on circumscribed choroidal haemangioma: A retrospective cohort study, Br. J. Ophthalmol., in press.","DOI":"10.1136\/bjo-2024-326759"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00417-005-0185-2","article-title":"Photodynamic therapy for choroidal hemangioma","volume":"244","author":"Shields","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/ijo.IJO_707_19","article-title":"Radiation therapy for exudative choroidal hemangioma","volume":"67","author":"Finger","year":"2019","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/archopht.122.11.1652","article-title":"Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment","volume":"122","author":"Aizman","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Dubar, P., Mathis, T., Hucteau, E., Thariat, J., Nhari, M., Maschi, C., Faber, C., Kiilgaard, J.F., Mosci, C., and Favard, C. (Acta Ophthalmol., 2025). A fast protocol for photodynamic therapy in exudative choroidal circumscribed hemangioma: Early laser irradiance after end of verteporfin infusion, Acta Ophthalmol., in press.","DOI":"10.1111\/aos.17513"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.oret.2020.04.018","article-title":"Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome","volume":"4","author":"Williams","year":"2020","journal-title":"Ophthalmol. Retin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/tjo.TJO-D-24-00154","article-title":"Diffuse choroidal hemangioma: IMRT versus episcleral plaque brachytherapy","volume":"15","author":"Ufondu","year":"2025","journal-title":"Taiwan. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000539384","article-title":"Ruthenium-106 Plaque Brachytherapy for Circumscribed Choroidal Hemangioma: A Case Series and Review of Literature","volume":"10","author":"Swaify","year":"2024","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102529","DOI":"10.1016\/j.pdpdt.2021.102529","article-title":"Circumscribed choroidal hemangioma: Comparative efficacy of transpupillary thermotherapy, indocyanine green-enhanced transpupillary thermotherapy, and photodynamic therapy","volume":"36","author":"Mirzayev","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3928\/15428877-20110707-01","article-title":"Transpupillary thermotherapy for circumscribed choroidal hemangioma: Clinical profile and treatment outcome","volume":"42","author":"Sharma","year":"2011","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0161-6420(99)00046-9","article-title":"Transpupillary thermotherapy for circumscribed choroidal hemangiomas","volume":"107","author":"Ramsay","year":"2000","journal-title":"Ophthalmology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yao, J., Yang, K., He, J., and Ran, L. (2025). Efficacy and safety of subthreshold micropulse laser in the treatment of central serous chorioretinopathy accompanied by choroidal hemangioma: A case report. BMC Ophthalmol., 25.","DOI":"10.1186\/s12886-025-03898-z"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10792-024-03238-y","article-title":"Management of circumscribed choroidal hemangioma at a tertiary care center","volume":"44","author":"Kiratli","year":"2024","journal-title":"Int. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ophtha.2020.07.026","article-title":"How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients","volume":"128","author":"Yousef","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamaophthalmol.2013.2879","article-title":"Failure of systemic propranolol therapy for choroidal hemangioma of Sturge-Weber syndrome: A report of 2 cases","volume":"131","author":"Krema","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.5301\/ejo.5000322","article-title":"Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome","volume":"23","author":"Thapa","year":"2013","journal-title":"Eur. J. Ophthalmol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/3087\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:59Z","timestamp":1760035619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/3087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":28,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17183087"],"URL":"https:\/\/doi.org\/10.3390\/cancers17183087","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}